ReviewPhysical medicine and rehabilitation clinics of North America2023
Cardiovascular Complications of Coronavirus Disease-2019.
Review in Physical medicine and rehabilitation clinics of North America, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 28 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
28 citing papers in PubMed, 1 synthesis or guideline pooled it, 47 citations in OpenAlex.
- A deeper look at long-term effects of COVID-19 on myocardial function in survivors with no prior heart diseases: a GRADE approach systematic review and meta-analysis.Frontiers in cardiovascular medicine · 2024Pooled it
- Article
- Analysis of factors associated with severe disease and construction of a monogram for elderly patients with community-acquired pneumonia complicated by heart failure.Pakistan journal of medical sciences · 2026Article
- Ischemic heart disease mortality with documented tobacco use in the United States, 1999-2023: a nationwide population-based analysis.Archives of public health = Archives belges de sante publique · 2026Article
- The 3C dataset: A comprehensive dataset for COVID-19 cardiac complications diagnosis.Data in brief · 2026Article
- Long term cardiometabolic outcomes in COVID positive patients.Journal of public health research · 2026Review
- The mortality burden from COVID in low-income settings: evidence from verbal autopsies in India.BMC public health · 2026Article
- Unraveling the cardiovascular burden of long COVID: symptom profiles, underlying mechanisms, and clinical management insights.Frontiers in cardiovascular medicine · 2026Review
- Pre- and during -COVID-19 pandemic mortality trends and drivers in rural, coastal Kenya: findings from the Kaloleni-Rabai Health and Demographic Surveillance System.Population health metrics · 2025Review
- Nationwide Trends in Hospitalizations for Sudden Cardiac Arrest Before and During the COVID Outbreak.Journal of clinical medicine · 2025Article
- Clinical and Proteomic Associations of SARS-CoV-2 Infection and COVID-19 Vaccination in Multimorbid Patients: A Cross-Sectional Observational Study.International journal of molecular sciences · 2025Observational
- Ischemic heart disease-related mortality trends in the United States (1999-2020) and prediction using machine learning.Annals of medicine and surgery (2012) · 2025Review
- COVID-19-Related Pathologies in Coronary Angiography in Patients with Acute Coronary Syndromes.Journal of clinical medicine · 2025Article
- The Involvement and Manifestations of SARS-CoV-2 Virus in Cardiovascular Pathology.Medicina (Kaunas, Lithuania) · 2025Review
- The Effect of COVID-19 on Arterial Stiffness and Inflammation: A Longitudinal Prospective Study.Viruses · 2025Article
- A Systematic Review of Case Reports of New-Onset Atrial Fibrillation in COVID-19 Patients.Cureus · 2025Review
- Therapeutic Flecainide Toxicity Causing VT Storm.JACC. Case reports · 2025Article
- COVID-19 as Potential Cause of Aortic Valvulitis.Methodist DeBakey cardiovascular journal · 2025Article
- Factors influencing the risk of cardiovascular complications following COVID-19 - clinical implications. The LATE-COVID study.Archives of medical science : AMS · 2025Article
- Cardiovascular abnormalities of long-COVID syndrome: Pathogenic basis and potential strategy for treatment and rehabilitation.Sports medicine and health science · 2024Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors at 2 institutions in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Cardiovascular complications associated with the severe acute respiratory syndrome coronavirus 2 infection are common and lead to high mortality in the acute phase and high morbidity in the chronic phase impacting an individual's quality of life and health outcomes. Patients afflicted with coronavirus disease-2019 (COVID-19) infection display an increased risk for myocarditis, dysrhythmia, pericarditis, ischemic heart disease, heart failure, and thromboembolism. Although cardiovascular complications are reported across all patients with COVID-19, hospitalized patients with severe infection are most vulnerable. The underline pathobiology remains poorly defined albeit complex. Following current guidelines in decision-making for evaluation and management in addition to the beginning or returning exercise is recommended.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.